Efficacy and Safety of Two Fixed-dose Combinations in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. (BENIPRO)

NCT06546735 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

816

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms

Interventions

DRUG: N0728
DRUG: Vesomni®

Sponsor

Eurofarma Laboratorios S.A.